Home Infusion Therapy Devices Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Global Home Infusion Therapy Devices Market By device Type (Infusion Pump, Needleless Connectors, Intravenous Set, Others), By Pump Type (Enteral Infusion Pump, Insulin Infusion Pump, Syringe Infusion Pump, Patient-Controlled Analgesia, Volumetric Infusion Pump, Others), By Application (Infectious Diseases, Pain Management, Enteral Nutrition, Chemotherapy, Total Parenteral Nutrition, Others), By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global home infusion therapy market size valued USD 17.6 billion and expected to reach USD 31.56 billion by 2027, at a CAGR of 8.7% during the period 2021-2027. Infusion therapy has become a common technique of pain relief, particularly for conditions when oral medicine is ineffective. The medication is frequently given intravenously or subcutaneously in this method. Patients are converting from traditional therapies to specialised infusion therapy treatments as a result of technological advancements. Home infusion therapy devices are used to administer drug solutions to treat various diseases that are unresponsive to the oral medication such as gastrointestinal diseases, cancer, and pain. Home infusion therapy devices also preferred in dehydration, diabetes, and cystic fibrosis treatment. Home infusion therapy declines the unplanned hospitalization and also improves the medication adherence. Most commonly used home infusion therapy devices for drug administration include intravenous set, needleless connectors, and infusion pumps among others. Due to increase in the prevalence of chronic diseases majorly diabetes and cancer and increase in awareness are anticipated to fuel the home infusion therapy devices market over the forecast period. Moreover, technological advancements such as the introduction of smart pumps that enhancing the overall ease of using home infusion devices are expected to drive market revenue. Furthermore, acquisitions and mergers, collaborations, and product launchings are the key strategies followed by the market players for generating larger revenue in the home infusion therapy devices market. For instance, in March 2016, PromptCare acquired Boston Home Infusion for expanding the product portfolio in Boston area. Similarly, in October 2016, ICU Medical Inc. acquired Hospira Infusion Systems for strengthening its home infusion therapy devices portfolio.

Home Infusion Therapy Devices Market

MARKET SUMMARY
-
8.7% CAGR
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 8.7%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Home Infusion Therapy Devices Market

  • The report on global home infusion therapy devices market gives historical, current and future market sizes (US$ Bn) based on device type, pump type, application, application and region.
  • home infusion therapy devices market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Fresenius Kabi AG
  • Braun Melsungen AG
  • ICU Medical, Inc.
  • Terumo Corporation
  • JMS Co. Ltd.
Home Infusion Therapy Devices Market

Drivers And Restraints

Increase in the demand for home infusion therapy from patients, high cost for hospitalization treatment, a wide range of applications with infusion devices, and presence of unmet medical needs are anticipated to fuel the home infusion therapy devices market over the forecast period. Moreover, increase in geriatric population, technological developments in home infusion therapy devices, and high prevalence of chronic diseases like diabetes and cancer are expected to boost the home infusion therapy devices market over the forecast period. However, the risk associated with the drug administration, product recalls, unfavorable reimbursement policies and misguidance about the usage of the device are impede the growth of home infusion therapy devices market over the forecast years.


North-America got significant share

Home Infusion Therapy Devices Market

Geographically, global home infusion therapy devices market segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North Americahome infusion therapy devices market growing due to increase in the awareness about home infusion therapy devices among key stakeholders, favorable reimbursement policies, and innovation of novel products are boosting the market. Europe home infusion therapy devices market expected to grow at a significant rate due to acquisitions between the companies for instance, in January 2015, Air Liquide acquired Optical Medical Therapies for expansion of business in German home infusion market. Asia Pacific expected to hold significant share owing to rise in patient awareness about home infusion therapy devices, adoption of newer devices, an increase in awareness about the advantages of home infusion therapy devices in the region. Latin Americahome infusion therapy devices market is projected to grow at a significant rate, which is attributed to the expansion of businesses by the market players, increase in the prevalence of cancer, and increase in geriatric population.Middle East and Africa driven by developing healthcare infrastructure and increase in the prevalence of chronic diseases like AIDS, cancer, and among others.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Notable Market Developments

  • In April 2017, Becton, Dickinson and company acquired Caesarea Medical Electronics for strengthening infusion system portfolio including home infusion therapy devices

Key

Key Features of the Report

Home Infusion Therapy Devices Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • Fresenius Kabi AG (Germany)
  • Braun Melsungen AG (Germany)
  • ICU Medical, Inc. (U.S.)
  • Terumo Corporation (Japan)
  • JMS Co. Ltd. (Japan)
  • Smiths Medical (U.S.)
  • Baxter International Inc. (U.S.)
  • Caesarea Medical Electronics Ltd. (Becton, Dickinson and Company) (U.S.)
  • Hoffmann-La Roche Ltd. (Switzerland)

Description

The global home infusion therapy market size valued USD 17.6 billion and expected to reach USD 31.56 billion by 2027, at a CAGR of 8.7% during the period 2021-2027. Infusion therapy has become a common technique of pain relief, particularly for conditions when oral medicine is ineffective. The medication is frequently given intravenously or subcutaneously in this method. Patients are converting from traditional therapies to specialised infusion therapy treatments as a result of technological advancements. Home infusion therapy devices are used to administer drug solutions to treat various diseases that are unresponsive to the oral medication such as gastrointestinal diseases, cancer, and pain. Home infusion therapy devices also preferred in dehydration, diabetes, and cystic fibrosis treatment. Home infusion therapy declines the unplanned hospitalization and also improves the medication adherence. Most commonly used home infusion therapy devices for drug administration include intravenous set, needleless connectors, and infusion pumps among others. Due to increase in the prevalence of chronic diseases majorly diabetes and cancer and increase in awareness are anticipated to fuel the home infusion therapy devices market over the forecast period. Moreover, technological advancements such as the introduction of smart pumps that enhancing the overall ease of using home infusion devices are expected to drive market revenue. Furthermore, acquisitions and mergers, collaborations, and product launchings are the key strategies followed by the market players for generating larger revenue in the home infusion therapy devices market. For instance, in March 2016, PromptCare acquired Boston Home Infusion for expanding the product portfolio in Boston area. Similarly, in October 2016, ICU Medical Inc. acquired Hospira Infusion Systems for strengthening its home infusion therapy devices portfolio.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX